Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

BACKGROUND: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of the body weight effects of concomitant medications (i.e., pharmacotherapies not specifically for the treatment of obesity) and functional foods, as well as adverse s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tondt, Justin, Bays, Harold Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661915/
https://www.ncbi.nlm.nih.gov/pubmed/37990714
http://dx.doi.org/10.1016/j.obpill.2022.100017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661915/
https://www.ncbi.nlm.nih.gov/pubmed/37990714
http://dx.doi.org/10.1016/j.obpill.2022.100017

Ejemplares similares